Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 27, 2024 - Issue 1
1,585
Views
0
CrossRef citations to date
0
Altmetric
Policy and Practice

Best practice recommendations for medically assisted reproduction in patients with known cardiovascular disease or at high risk of cardiovascular disease

A consensus statement supported by the UK Maternal Cardiology Society (UKMCS), British Fertility Society, MacDonald Obstetric Medicine Society (MOMS), British Cardiovascular Society (BCS), British Cardiovascular Intervention Society (BCIS), British Society for Heart Failure (BSH), Scottish Obstetric Cardiac Network (SOCN), Royal College of Obstetricians and Gynaecologists (RCOG), Association of Anaesthetists, Fertility UK, Primary Care Cardiovascular Society (PCCS), Obstetric Anaesthetists Association (OAA), Association of Inherited Cardiac Conditions (AICC)

, , , , , , , , , , , , & show all
Article: 2278295 | Received 02 Oct 2023, Accepted 02 Oct 2023, Published online: 09 Jan 2024

References

  • Academy of Medical Royal Colleges (AoMRC). (2021). https://www.aomrc.org.uk/wp-content/uploads/2021/02/Safe_sedation_practice_for_healthcare_procedures_update_0521.pdf#:∼:text=Sedation%20for%20therapeutic%20and%20investigative%20procedures%20in%20healthcare,required%20for%20the%20safe%20delivery%20of%20effective%20sedation
  • Al-Inany, H. G., Youssef, M. A., Ayeleke, R. O., Brown, J., Lam, W. S., & Broekmans, F. J. (2016). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane Database of Systematic Reviews, 4(4), CD001750. https://doi.org/10.1002/14651858.CD001750.pub4
  • Atkinson, T. M., Giraud, G. D., Togioka, B. M., Jones, D. B., & Cigarroa, J. E. (2017). Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation, 135(7), 700–710. https://doi.org/10.1161/CIRCULATIONAHA.116.023262
  • Bailey, C. R., Ahuja, M., Bartholomew, K., Bew, S., Forbes, L., Lipp, A., Montgomery, J., Russon, K., Potparic, O., & Stocker, M. (2019). Guidelines for day-case surgery 2019: Guidelines from the Association of Anaesthetists and the British Association of Day Surgery. Anaesthesia, 74(6), 778–792. https://doi.org/10.1111/anae.14639
  • Berthiller, J., & Sasco, A. J. (2005). Tabagisme (actif ou passif) en relation avec la fertilité, la procréation médicalement assistée et la grossesse [Smoking (active or passive) in relation to fertility, medically assisted procreation and pregnancy]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 34 (1), 47–54. https://doi.org/10.1016/S0368-2315(05)82970-9
  • Bouma, B. J., & Mulder, B. J. (2017). Changing landscape of congenital heart disease. Circulation Research, 120(6), 908–922. https://doi.org/10.1161/CIRCRESAHA.116.309302
  • Bramham, K., Parnell, B., Nelson-Piercy, C., Seed, P. T., Poston, L., & Chappell, L. C. (2014). Chronic hypertension and pregnancy outcomes: Systematic review and meta-analysis. BMJ (Clinical Research ed.), 348, g2301. https://doi.org/10.1136/bmj.g2301
  • British Heart Foundation. (2019). BHF statistics Compendium 2019. https://www.bhf-statistics-compendium-2022.pdf
  • Busnelli, A., Schirripa, I., Fedele, F., Bulfoni, A., & Levi-Setti, P. E. (2022). Obstetric and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: A systematic review and meta-analysis. Human Reproduction (Oxford, England), 37(7), 1619–1641. https://doi.org/10.1093/humrep/deac073
  • Cheitlin, M. D. (2003). Sexual activity and cardiovascular disease. The American Journal of Cardiology, 92(9A), 3M–8M. https://doi.org/10.1016/s0002-9149(02)03367-2
  • Dayan, N., Laskin, C. A., Spitzer, K., Mason, J., Udell, J. A., Wald, R. M., Siu, S. C., Iten-Scott, T., & Silversides, C. K. (2014). Pregnancy complications in women with heart disease conceiving with fertility therapy. Journal of the American College of Cardiology, 64(17), 1862–1864. https://doi.org/10.1016/j.jacc.2014.07.977
  • Denison, F. C., Aedla, N. R., Keag, O., Hor, K., Reynolds, R. M., Milne, A., & Diamond, A. (2019). Care of women with obesity in pregnancy: Green-top Guideline No. 72. BJOG: An International Journal of Obstetrics & Gynaecology, 126(3), e62–e106. https://doi.org/10.1111/1471-0528.15386
  • European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J. M., Gibbs, J. S., Gohlke-Baerwolf, C., Gorenek, B., Iung, B., Kirby, M., Maas, A. H., Morais, J., Nihoyannopoulos, P., Pieper, P. G., Presbitero, P., Roos-Hesselink, J. W., … ESC Committee for Practice Guidelines (2011). ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal, 32(24), 3147–3197. https://doi.org/10.1093/eurheartj/ehr218
  • Fiedler, K., & Ezcurra, D. (2012). Predicting and preventing ovarian hyperstimulation syndrome (OHSS): The need for individualized not standardized treatment. Reproductive Biology and Endocrinology: RB&E, 10(1), 32. https://doi.org/10.1186/1477-7827-10-32
  • Fujitake, E., Jaspal, R., Monasta, L., Stampalija, T., & Lees, C. (2020). Acute cardiovascular changes in women undergoing in vitro fertilisation (IVF), a systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 248, 245–251. https://doi.org/10.1016/j.ejogrb.2020.01.033
  • Graham, D. F., & Raal, F. J. (2021). Management of familial hypercholesterolemia in pregnancy. Current Opinion in Lipidology, 32(6), 370–377. https://doi.org/10.1097/MOL.0000000000000790
  • Henriksson, P., Westerlund, E., Wallén, H., Brandt, L., Hovatta, O., & Ekbom, A. (2013). Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: Cross sectional study. BMJ (Clinical Research ed.), 346, e8632. https://doi.org/10.1136/bmj.e86326
  • Humaidan, P., Quartarolo, J., & Papanikolaou, E. G. (2010). Preventing ovarian hyperstimulation syndrome: Guidance for the clinician. Fertility and Sterility, 94(2), 389–400. https://doi.org/10.1016/j.fertnstert.2010.03.028
  • Human Fertilisation and Embryology Authority. (2019). Fertility treatment 2019: Trends and figures. https://www.hfea.gov.uk/about-us/publications/research-and-data/fertility-treatment-2019-trends-and-figures/#Section1
  • Human Fertilisation and Embryology Authority. (2018). Our national patient survey results | HFEA. https://www.hfea.gov.uk/about-us/news-and-press-releases/2018-news-and-press-releases/our-national-patient-survey-results/
  • HFEA. (n.d). https://www.hfea.gov.uk/pgt-m-conditions/ https://www.hfea.gov.uk/media/h1jhkpy2/2023-09-21-pgt-m-full-approved-condition-list.xlsx
  • Jaspal, R., Prior, T., Denton, J., Salim, R., Banerjee, J., & Lees, C. (2019). The impact of cross-border IVF on maternal and neonatal outcomes in multiple pregnancies: Experience from a UK fetal medicine service. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 238, 63–67. https://doi.org/10.1016/j.ejogrb.2019.04.030
  • Kametas, N. A., McAuliffe, F., Krampl, E., Chambers, J., & Nicolaides, K. H. (2003). Maternal cardiac function in twin pregnancy. Obstetrics and Gynecology, 102(4), 806–815. https://doi.org/10.1016/s0029-7844(03)00807-x
  • Kim, Y. Y., Levine, L. D., Partington, S. L., Patel, P. A., Ruckdeschel, E., Senapati, S., & Gracia, C. R. (2020). Successful in vitro fertilization in women with Fontan physiology. Journal of Assisted Reproduction and Genetics, 37(12), 3017–3023. https://doi.org/10.1007/s10815-020-01969-2
  • Klein, A. A., Meek, T., Allcock, E., Cook, T. M., Mincher, N., Morris, C., Nimmo, A. F., Pandit, J. J., Pawa, A., Rodney, G., Sheraton, T., & Young, P. (2021). Recommendations for standards of monitoring during anaesthesia and recovery 2021: Guideline from the Association of Anaesthetists. Anaesthesia, 76(9), 1212–1223. https://doi.org/10.1111/anae.15501
  • Lensen, S. F., Wilkinson, J., Leijdekkers, J. A., La Marca, A., Mol, B. W. J., Marjoribanks, J., Torrance, H., & Broekmans, F. J. (2018). Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). The Cochrane Database of Systematic Reviews, 2(2), CD012693. https://doi.org/10.1002/14651858.CD012693.pub2
  • Levi-Setti, P. E., Cirillo, F., Scolaro, V., Morenghi, E., Heilbron, F., Girardello, D., Zannoni, E., & Patrizio, P. (2018). Appraisal of clinical complications after 23,827 oocyte retrievals in a large assisted reproductive technology program. Fertility and Sterility, 109(6), 1038–1043.e1. https://doi.org/10.1016/j.fertnstert.2018.02.002
  • Levine, G. N., Steinke, E. E., Bakaeen, F. G., Bozkurt, B., Cheitlin, M. D., Conti, J. B., Foster, E., Jaarsma, T., Kloner, R. A., Lange, R. A., Lindau, S. T., Maron, B. J., Moser, D. K., Ohman, E. M., Seftel, A. D., & Stewart, W. J. (2012). Sexual activity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation, 125(8), 1058–1072. https://doi.org/10.1161/CIR.0b013e3182447787
  • Li, Y., Sun, X., Zang, L., Zhang, Q., Li, J., & Zou, S. (2013). Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation. Endocrine, 44(3), 784–789. https://doi.org/10.1007/s12020-013-9953-7
  • Magnus, M. C., Fraser, A., Håberg, S. E., Rönö, K., Romundstad, L. B., Bergh, C., Spangmose, A. L., Pinborg, A., Gissler, M., Wennerholm, U. B., Åsvold, B. O., Lawlor, D. A., & Opdahl, S. (2023). maternal risk of cardiovascular disease after use of assisted reproductive technologies. JAMA Cardiology, 8(9), 837–845. https://doi.org/10.1001/jamacardio.2023.2324
  • MBRRACE-UK. (2021). Maternal Report 2021. https://www.npeu.ox.ac.uk/assets/downloads/mbrrace-uk/reports/maternal-report-2021/MBRRACE-UK_Maternal_Report_2021_-_FINAL_-_WEB_VERSION.pdf
  • Membership of the Working Party:, Whitaker, D. K., Booth, H., Clyburn, P., Harrop-Griffiths, W., Hosie, H., Kilvington, B., Macmahon, M., Smedley, P., Verma, R., & Association of Anaesthetists of Great Britain and Ireland (2013). Immediate post-anaesthesia recovery 2013: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia, 68(3), 288–297. https://doi.org/10.1111/anae.12146
  • Mittal, M., McEniery, C., Supramaniam, P. R., Cardozo, L., Savvas, M., Panay, N., & Hamoda, H. (2022). Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: A randomised pilot trial. Maturitas, 161, 18–26. https://doi.org/10.1016/j.maturitas.2022.01.012
  • Mocanu, E., Redmond, M. L., Hennelly, B., Collins, C., & Harrison, R. (2007). Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment. Human Fertility (Cambridge, England), 10(3), 175–181. https://doi.org/10.1080/14647270701194143
  • NICE. (2019). Hypertension in pregnancy: Diagnosis and management NICE guideline [NG133]. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwioisKd6vyBAxVEhv0HHdt_AZgQFnoECCUQAQ&url=https%3A//www.nice.org.uk/guidance/ng133/resources/hypertension-in-pregnancy-diagnosis-and-management-pdf-66141717671365&usg=AOvVaw1XrPlNwAkWn7ngj_q0yJvD&opi=89978449
  • Olausson, N., Discacciati, A., Nyman, A. I., Lundberg, F., Hovatta, O., Westerlund, E., Wallén, H. N., Mobarrez, F., Bottai, M., Ekbom, A., & Henriksson, P. (2020). Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: Nationwide cohort study. Journal of Thrombosis and Haemostasis: JTH, 18(8), 1965–1973. https://doi.org/10.1111/jth.14840
  • Ombelet, W., Martens, G., De Sutter, P., Gerris, J., Bosmans, E., Ruyssinck, G., Defoort, P., Molenberghs, G., & Gyselaers, W. (2006). Perinatal outcome of 12,021 singleton and 3108 twin births after non-IVF-assisted reproduction: A cohort study. Human Reproduction (Oxford, England), 21(4), 1025–1032. https://doi.org/10.1093/humrep/dei419
  • Øyen, N., Boyd, H. A., Carstensen, L., Søndergaard, L., Wohlfahrt, J., & Melbye, M. (2022). Risk of congenital heart defects in offspring of affected mothers and fathers. Circulation. Genomic and Precision Medicine, 15(4), e003533. https://doi.org/10.1161/CIRCGEN.121.003533
  • Qin, J., Liu, X., Sheng, X., Wang, H., & Gao, S. (2016). Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: A meta-analysis of cohort studies. Fertility and Sterility, 105(1), 73–85.e1–6. https://doi.org/10.1016/j.fertnstert.2015.09.007
  • Quien, M. M., Hausvater, A., Maxwell, S. M., & Weinberg, C. R. (2022). Assisted reproductive technology outcomes in women with heart disease. Frontiers in Cardiovascular Medicine, 9, 842556. https://doi.org/10.3389/fcvm.2022.842556
  • Regitz-Zagrosek, V., Roos-Hesselink, J., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., Marthe Lang, I., Morais, J., Pieper, P. G., Presbitero, P., Price, S., Rosano, G. M. C., Seeland, U., Simoncini, T., Swan, L., Warnes, C. A. (2018). 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal, 39(34):3165–3241. https://doi.org/10.1093/eurheartj/ehy340.
  • Roos-Hesselink, J., Baris, L., Johnson, M., De Backer, J., Otto, C., Marelli, A., Jondeau, G., Budts, W., Grewal, J., Sliwa, K., Parsonage, W., Maggioni, A. P., van Hagen, I., Vahanian, A., Tavazzi, L., Elkayam, U., Boersma, E., & Hall, R. (2019). Pregnancy outcomes in women with cardiovascular disease: Evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). European Heart Journal, 40(47), 3848–3855. https://doi.org/10.1093/eurheartj/ehz136
  • Schofield, S. J., Doughty, V. L., van Stiphout, N., Franklin, R. C. G., Johnson, M. R., Daubeney, P. E. F., & Cullinan, P. (2017). Assisted conception and the risk of CHD: A case-control study. Cardiology in the Young, 27(3), 473–479. https://doi.org/10.1017/S1047951116000743
  • Sennström, M., Rova, K., Hellgren, M., Hjertberg, R., Nord, E., Thurn, L., & Lindqvist, P. G. (2017). Thromboembolism and in vitro fertilization - A systematic review. Acta Obstetricia et Gynecologica Scandinavica, 96(9), 1045–1052. https://doi.org/10.1111/aogs.13147
  • Silversides, C. K., Grewal, J., Mason, J., Sermer, M., Kiess, M., Rychel, V., Wald, R. M., Colman, J. M., & Siu, S. C. (2018). Pregnancy outcomes in women with heart disease: The CARPREG II Study. Journal of the American College of Cardiology, 71(21), 2419–2430. https://doi.org/10.1016/j.jacc.2018.02.076
  • Skorupskaite, K., Joy, E., Balen, A., Agarwal, K., Cauldwell, M., & English, K. (2022). Assisted reproduction in patients with cardiac disease: A retrospective review. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 276, 199–203. https://doi.org/10.1016/j.ejogrb.2022.07.020
  • Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., & Norman, R. J. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction (Oxford, England), 34(2), 388–1618. https://doi.org/10.1093/humrep/dey256
  • van der Linden, M., Buckingham, K., Farquhar, C., Kremer, J. A., & Metwally, M. (2015). Luteal phase support for assisted reproduction cycles. The Cochrane Database of Systematic Reviews, 2015(7), CD009154. https://doi.org/10.1002/14651858.CD009154.pub3
  • Wang, R., Li, W., Bordewijk, E. M., Legro, R. S., Zhang, H., Wu, X., Gao, J., Morin-Papunen, L., Homburg, R., König, T. E., Moll, E., Kar, S., Huang, W., Johnson, N. P., Amer, S. A., Vegetti, W., Palomba, S., Falbo, A., Özmen, Ü., … Mol, B. W. (2019). First-line ovulation induction for polycystic ovary syndrome: An individual participant data meta-analysis. Human Reproduction Update, 25(6), 717–732. https://doi.org/10.1093/humupd/dmz029
  • Whicher, C. A., O'Neill, S., & Holt, R. I. G. (2020). Diabetes in the UK: 2019. Diabetic Medicine: A Journal of the British Diabetic Association, 37(2), 242–247. https://doi.org/10.1111/dme.14225
  • WHO CVD Risk Chart Working Group. (2019). World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. The Lancet. Global Health, 7(10), e1332–e1345. https://doi.org/10.1016/S2214-109X(19)30318-3
  • Witz, C. A., Daftary, G. S., Doody, K. J., Park, J. K., Seifu, Y., Yankov, V. I., & Heiser, P. W. (2020). Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection. Fertility and Sterility, 114(2), 321–330. https://doi.org/10.1016/j.fertnstert.2020.03.029
  • Yinon, Y., Pauzner, R., Dulitzky, M., Elizur, S. E., Dor, J., & Shulman, A. (2006). Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reproductive Biomedicine Online, 12(3), 354–358. https://doi.org/10.1016/s1472-6483(10)61009-7
  • Youssef, M. A., Van der Veen, F., Al-Inany, H. G., Mochtar, M. H., Griesinger, G., Nagi Mohesen, M., Aboulfoutouh, I., & van Wely, M. (2014). Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. The Cochrane Database of Systematic Reviews, 2014(10), CD008046. https://doi.org/10.1002/14651858.CD008046.pub4